Abstract: An illuminating device (10). In one embodiment, the illuminating device includes a light source (12), optical components (16, 18, 20) that define a plurality of light paths (14) originating from the light source, a light-conditioning array (22) on at least one of the plurality of light paths, at least one light output (34) to which an associated device that is to be supplied with light or conditioned light is connectable, at least one light path-selecting unit (24) which is provided with several input light path sections associated with another light path and at least one output light path section leading to said light output or another associated light output.

Abstract: Disclosed is an illuminating device (10) comprising a light source (12), optical components (16, 18, 20) that define a plurality of light paths (14) originating from the light source, a light-conditioning array (22) on at least one of said light paths, a least one light output (34) to which an associated device that is to be supplied with light or conditioned light is or can be connected, at least one light path-selecting unit (24) which is provided with several input light path sections associated with another light path and at least one output light path section leading to said light output or another associated light output. Each light path can optionally be connected to the light output via the output light path section or to a predefined or selected light output via a predefined or selected output light path section as the selected light path in a corresponding selection mode of the light path-selecting unit by means of the light path-selecting unit that can be switched between several selection modes.

Abstract: The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives, which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.

Abstract: The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aninomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl radical, and of their salts for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders.

Abstract: The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl radical, and of their salts for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders.

Abstract: The invention relates to the use of substituted 2-aminothiazoles for promoting wound healing.

Abstract: The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.

Abstract: The invention relates to heteroatom-containing benzocyclopentaneoxazolidinones, to processes for their preparation and their use as medicaments, especially as antibacterial medicaments.

Abstract: The present invention relates to (2-aminoacylamino-2-deoxy-glycosyl)-amides, which are substituted on the nitrogen atom of the amino acid, of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation and to their use in medicaments.

Abstract: The present invention relates to (2-aminoacylamino-2-deoxy-glycosyl)-amides, which are substituted on the nitrogen atom of the amino acid, of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation and to their use in medicaments.

Abstract: The invention relates to 6-membered nitrogen-containing heteroaryloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

Abstract: The present invention relates to 5-membered heteroaryl-oxazolidinones, to processes for their preparation and to their use as medicaments, in particular as antibacterial medicaments.

Abstract: The present invention relates to benzofuranyl- and benzothienyloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

Abstract: The invention relates to 6-membered nitrogen-containing heteroaryloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

Abstract: The invention relates to benzoxazolyl- and benzothiazolyloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

Abstract: There are provided new substituted 3-aryl-pyrrolidine-2,4-diones of the formula ##STR1## in which X represents hydrogen, alkyl, halogen or alkoxy,Y represents hydrogen, alkyl, halogen, alkoxy or halogenoalkyl,Z represents alkyl, halogen or alkoxy,n represents a number from 0-3,R represents hydrogen or the groups--CO--R.sup.1, --CO--O--R.sup.2in whichR.sup.1 and R.sup.2 have the meanings given in the text of the application,A represents optionally halogen-substituted alkyl, alkenyl, alkinyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl and cycloalkyl which is optionally interrupted by hetero atoms, or represents arylakyl which is optionally substituted by halogen, alkyl, halogenoalkyl, alkoxy or nitro,B represents optionally substituted aryl or benzyl.The new compounds of the formula (I) have highly pronounced insecticidal, acaricidal, fungicidal and antimycotic properties.

Abstract: Nikkomycin compounds have been found to be orally or parenterally effective as anti-fungals in animals. They may be used alone or, preferably, in combination with azole antimycotics for a synergistic anti-fungal effect.

Abstract: 1-Trifluoromethyl-1-nitro-2-alkoxy-2-aryl-ethanes of the formula ##STR1## in which R.sup.1 represents a straight-chain or branched alkyl radical andR.sup.2 represents an optionally substituted aryl or hetaryl radical,their preparation from an aldehyde of the formula R.sup.2 --CHO, an alcohol of the formula R.sup.1 --OH and trifluoromethylnitromethane in the presence of a compound containing basic groups and antimycotic agents containing these compounds.

Abstract: Nikkomycin compounds have been found to be orally or parenterally effective as anti-fungals in animals. They may be used alone or, preferably, in combination with azole antimycotics for a synergistic anti-fungal effect.

Abstract: Insecticidal, acaricidal, herbicidal and antimycotic 3-aryl-pyrrolidine-2,4-diones of the formula ##STR1## in which X represents alkyl, halogen or alkoxy,Y represents hydrogen, alkyl, halogen, alkoxy or halogenoalkyl,Z represents alkyl, halogen or alkoxy,n represents a number from 0-3,R represents hydrogen or represents the groups --CO--R.sup.1 or --CO--O--R.sup.2,in whichR.sup.1 represents alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl, polyalkoxyalkyl or cycloalkyl which can be interrupted by hetero atoms, each of which radicals is optionally substituted by halogen, or represents optionally substituted phenyl, optionally substituted phenylalkyl, substituted hetaryl, substituted phenoxyalkyl or substituted hetaryloxyalkyl, or represents optionally substituted phenyl, optionally substituted phenylalkyl, substituted hetaryl, substituted phenoxyalkyl and substituted hetaryloxyalkyl, andR.sup.